PubMed · 8870156
Some optimal and non-optimal two-stage designs using an alpha-spending function.
Abstract
While designing a group sequential clinical trial in the pharmaceutical industry setting, we often face a problem of determining the time for an interim analysis. For a two-stage trial we compute the sample sizes n and N per treatment group for the interim and final analyses, respectively, that minimize the average trial size for a specified overall power. We consider this optimization when we monitor the trial using a Lan-DeMets alpha-spending function. Two additional problems considered in this context are (i) finding the sample sizes that maximize the overall power for a specified average trial size, and (ii) finding the sample sizes that achieve specified powers at the interim and final analyses.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
H I Patel. 1996-08-30. Some optimal and non-optimal two-stage designs using an alpha-spending function.. https://doi.org/10.1002/(sici)1097-0258(19960830)15%3A16%3C1739%3A%3Aaid-sim341%3E3.0.co%3B2-t
Cite the original work for its findings. Save a collection to share your selection of sources.